title: Dental management of patients receiving anticoagulant and/or antiplatelet treatment.
abstract: BACKGROUND
  Adequate hemostasis is crucial for the success of invasive dental treatment, since bleeding problems can give rise to complications associated with important morbidity-mortality. The dental treatment of patients who tend to an increased risk of bleeding due to the use of anticoagulant and/or antiplatelet drugs raises a challenge in the daily practice of dental professionals. Adequate knowledge of the mechanisms underlying hemostasis, and the optimized management of such patients, are therefore very important issues.
  
  
  OBJECTIVE
  A study is made of the anticoagulant / antiplatelet drugs currently available on the market, with evaluation of the risks and benefits of suspending such drugs prior to invasive dental treatment. In addition, a review is made of the current management protocols used in these patients.
  
  
  METHODS
  A literature search was made in the PubMed, Cochrane Library and Scopus databases, covering all studies published in the last 5 years in English and Spanish. Studies conducted in humans and with scientific evidence levels 1 and 2 (metaanalyses, systematic reviews, randomized phase 1 and 2 trials, cohort studies and case-control studies) were considered. The keywords used for the search were: tooth extraction, oral surgery, hemostasis, platelet aggregation inhibitors, antiplatelet drugs, anticoagulants, warfarin, acenocoumarol.
  
  
  CONCLUSIONS
  Many management protocols have been developed, though in all cases a full clinical history is required, together with complementary hemostatic tests to minimize any risks derived from dental treatment. Many authors consider that patient medication indicated for the treatment of background disease should not be altered or suspended unless so indicated by the prescribing physician. Local hemostatic measures have been shown to suffice for controlling possible bleeding problems resulting from dental treatment. Key words:Tooth extraction, oral surgery, hemostasis, platelet aggregation inhibitors, antiplatelet drugs, anticoagulants, warfarin, acenocoumarol.
authors.affiliation: Degree in Dental Surgery. Master in Oral Medicine and Surgery. Valencia University Medical and Dental School. Valencia, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Mingarro-de-León
authors.affiliation: Degree in Dental Surgery. Master in Oral Medicine and Surgery. Valencia University Medical and Dental School. Valencia, Spain.
authors.forename: Begonya
authors.initials: B
authors.lastname: Chaveli-López
authors.affiliation: Associate Professor of Oral Medicine. Valencia University Medical and Dental School. Valencia, Spain.
authors.forename: Carmen
authors.initials: C
authors.lastname: Gavaldá-Esteve